Christopher J. Kirk

Person

San Francisco, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Immunoglobulin expression levels as biomarker for proteasome inhibi...
- Patent number 10,870,889
- Issue date Dec 22, 2020
- Onyx Therapeutics, Inc.
- Brian Tuch
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Immunoglobulin expression levels as biomarker for proteasome inhibi...
- Patent number 10,662,479
- Issue date May 26, 2020
- Onyx Therapeutics, Inc.
- Brian Tuch
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Liposomal compositions of epoxyketone-based proteasome inhibitors
- Patent number 10,022,326
- Issue date Jul 17, 2018
- Onyx Therapeutics, Inc.
- Katherine A. Chu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modified release formulations for oprozomib
- Patent number 9,295,708
- Issue date Mar 29, 2016
- Onyx Therapeutics, Inc.
- Mouhannad Jumaa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Use of peptide epoxyketones for metastasis suppression
- Patent number 8,853,147
- Issue date Oct 7, 2014
- Onyx Therapeutics, Inc.
- Christopher J. Kirk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
IMMUNOGLOBULIN EXPRESSION LEVELS AS BIOMARKER FOR PROTEASOME INHIBI...
- Publication number 20230235406
- Publication date Jul 27, 2023
- Onyx Therapeutics, Inc.
- Brian TUCH
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
IMMUNOGLOBULIN EXPRESSION LEVELS AS BIOMARKER FOR PROTEASOME INHIBI...
- Publication number 20210238691
- Publication date Aug 5, 2021
- Onyx Therapeutics, Inc.
- Brian TUCH
- G01 - MEASURING TESTING
Information Patent Application
Immunoglobulin Expression Levels as Biomarker for Proteasome Inhibi...
- Publication number 20200354793
- Publication date Nov 12, 2020
- Amgen Inc.
- Brian Tuch
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
PEPTIDE EPOXYKETONE PROTEASOME INHIBITORS IN COMBINATION WITH PIM K...
- Publication number 20200289606
- Publication date Sep 17, 2020
- Onyx Therapeutics, Inc.
- Shirin Kapur
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PEPTIDE EPOXYKETONE PROTEASOME INHIBITORS IN COMBINATION WITH PIM K...
- Publication number 20190224270
- Publication date Jul 25, 2019
- Onyx Therapeutics, Inc.
- Shirin Kapur
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MODIFIED RELEASE FORMULATIONS FOR OPROZOMIB
- Publication number 20160213610
- Publication date Jul 28, 2016
- Onyx Therapeutics, Inc.
- Mouhannad Jumaa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
IMMUNOGLOBULIN EXPRESSION LEVELS AS BIOMARKER FOR PROTEASOME INHIBI...
- Publication number 20160177402
- Publication date Jun 23, 2016
- Onyx Therapeutics, Inc.
- Brian Tuch
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
PEPTIDE EPOXYKETONE PROTEASOME INHIBITORS IN COMBINATION WITH PIM K...
- Publication number 20160166632
- Publication date Jun 16, 2016
- Onyx Therapeutics, Inc.
- Shirin Kapur
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LIPOSOMAL COMPOSITIONS OF EPOXYKETONE-BASED PROTEASOME INHIBITORS
- Publication number 20150209281
- Publication date Jul 30, 2015
- Onyx Therapeutics, Inc.
- Katherine A. Chu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
LIPOSOMAL COMPOSITIONS OF EPOXYKETONE-BASED PROTEASOME INHIBITORS
- Publication number 20150209282
- Publication date Jul 30, 2015
- Onyx Therapeutics, Inc.
- Katherine A. Chu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
USE OF PEPTIDE EPOXYKETONES FOR METASTASIS SUPPRESSION
- Publication number 20140364377
- Publication date Dec 11, 2014
- Christopher J. Kirk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Modified Release Formulations for Oprozomib
- Publication number 20140113855
- Publication date Apr 24, 2014
- Mouhannad Jumaa
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Use of Peptide Epoxyketones for Metastasis Suppression
- Publication number 20130035295
- Publication date Feb 7, 2013
- Christopher J. Kirk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION THERAPY WITH PEPTIDE EPOXYKETONES
- Publication number 20110236428
- Publication date Sep 29, 2011
- Onyx Therapeutics, Inc.
- Christopher J. Kirk
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Christopher J. Kirk

Person

Patents Grantslast 30 patents

Immunoglobulin expression levels as biomarker for proteasome inhibi...

Immunoglobulin expression levels as biomarker for proteasome inhibi...

Liposomal compositions of epoxyketone-based proteasome inhibitors

Modified release formulations for oprozomib

Use of peptide epoxyketones for metastasis suppression

Patents Applicationslast 30 patents

IMMUNOGLOBULIN EXPRESSION LEVELS AS BIOMARKER FOR PROTEASOME INHIBI...

IMMUNOGLOBULIN EXPRESSION LEVELS AS BIOMARKER FOR PROTEASOME INHIBI...

Immunoglobulin Expression Levels as Biomarker for Proteasome Inhibi...

PEPTIDE EPOXYKETONE PROTEASOME INHIBITORS IN COMBINATION WITH PIM K...

PEPTIDE EPOXYKETONE PROTEASOME INHIBITORS IN COMBINATION WITH PIM K...

MODIFIED RELEASE FORMULATIONS FOR OPROZOMIB

IMMUNOGLOBULIN EXPRESSION LEVELS AS BIOMARKER FOR PROTEASOME INHIBI...

PEPTIDE EPOXYKETONE PROTEASOME INHIBITORS IN COMBINATION WITH PIM K...

LIPOSOMAL COMPOSITIONS OF EPOXYKETONE-BASED PROTEASOME INHIBITORS

LIPOSOMAL COMPOSITIONS OF EPOXYKETONE-BASED PROTEASOME INHIBITORS

USE OF PEPTIDE EPOXYKETONES FOR METASTASIS SUPPRESSION

Modified Release Formulations for Oprozomib

Use of Peptide Epoxyketones for Metastasis Suppression

COMBINATION THERAPY WITH PEPTIDE EPOXYKETONES